CEP-11981
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CEP-11981, covering 2012-07-25 to 2012-07-25. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced Cancer [Phase 1]